Highlights: Key Opinion Leader Event on Bone Marrow Transplant, Potential Role of Iomab-B

Highlights Segment from Bone Marrow Transplantation and Radioimmunotherapy

Phase III Drug Candidate: Iomab-B

Hillard Lazarus MD, Professor of Medicine at Case Western Reserve University

Roland Turck MD, Radiopharmaceutical Veteran with Extensive Drug Commercialization Experience


View full-length panel discussion »